0001836740-20-000001.txt : 20201217 0001836740-20-000001.hdr.sgml : 20201217 20201217140550 ACCESSION NUMBER: 0001836740-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 EFFECTIVENESS DATE: 20201217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avilar Therapeutics, Inc. CENTRAL INDEX KEY: 0001836740 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383553 FILM NUMBER: 201395418 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-475-8493 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001836740 Avilar Therapeutics, Inc. 200 BERKELEY STREET 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 617-475-8493 MASSACHUSETTS None None Corporation true 2020 Milind Deshpande 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director David Neafus 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Joshua Resnick 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Theresa Cameron 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Pharmaceuticals Decline to Disclose 06b false 2020-12-14 false true false 0 60000000 20276164 39723836 false 3 0 0 0 false Avilar Therapeutics, Inc. /s/ Milind Deshpande Milind Deshpande President 2020-12-17